P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells

Abstract P2Y12 blockade improves patient outcomes after myocardial infarction.As well as antithrombotic effects, anti-inflammatory effects may contribute to this beneficial clinical outcome.Here we aimed to identify potential anti-inflammatory effects of P2Y12 receptor blockers on monocytes Food Mills and macrophages.Using flow cytometry, migration

read more